Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study-Reference-Cited by-同舟云学术

Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study

Published:2016-07-04 Issue:9 Volume:108 Page:djw133
ISSN:0027-8874
Container-title:Journal of the National Cancer Institute
language:en
Short-container-title:JNCI J Natl Cancer Inst

Author:

Ohri Nitin,Dawson Laura A.,Krishnan Sunil,Seong Jinsil,Cheng Jason C.,Sarin Shiv K.,Kinkhabwala Milan,Ahmed Mansoor M.,Vikram Bhadrasain,Coleman C. Norman,Guha Chandan

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/108/9/djw133/18077458/djw133.pdf

Reference130 articles.

1. World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective;Ferenci;J Gastrointestin Liver Dis.,2010

2. Global cancer statistics

3. Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

4. Utilization and Outcomes of Palliative Therapy for Hepatocellular Carcinoma

5. Sorafenib in Advanced Hepatocellular Carcinoma

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging SEER data through machine learning to predict distant lymph node metastasis and prognosticate outcomes in hepatocellular carcinoma patients;The Journal of Gene Medicine;2024-08-26

2. Liver-Directed Combined Radiation Therapy for Downstaging Beyond-Milan Hepatocellular Carcinoma to Liver Transplantation;International Journal of Radiation Oncology*Biology*Physics;2024-07

3. The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma;Molecular Carcinogenesis;2024-06-05

4. Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial;BMJ Open;2024-06

5. Prognostic model and ceRNA network of m7G- and radiosensitivity-related genes in hepatocellular carcinoma;Heliyon;2024-05